Tobacco Interests Contribute a Portion Of the $109 Million Raised by SU2C

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Over the past seven years, as Steven K. Libutti was designing the 12-story, $900-plus million cancer hospital in New Brunswick, NJ, he often thought of the functionality of the building that inspired it: Building 10, the NIH Clinical Center.

April 25, 2025

By Paul Goldberg

Guest Editorial

In her own words: Rathmell reflects on her priorities and values—and encourages everyone to do the same

I did not find the process of being suddenly without employment as refreshing as one might think. It did, however, provide a forced opportunity to engage in self-reflection, to critically analyze the situation around cancer, and to face the complex set of problems that cancer, and society, present to us.

April 25, 2025

By W. Kimryn Rathmell

Regulatory News

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas

In his first sit-down interview since beginning his role as FDA commissioner 17 days earlier, Marty Makary, a former Johns Hopkins surgeon and the only Trump pick for HHS whose confirmation received Democratic support, said he would speed up approvals for rare-disease treatments by reducing reliance on animal testing and shifting towards organoids and computational models.

April 25, 2025

By Claire Marie Porter

Cancer Policy

White House preliminary budget document provides no funds for highly impactful CDC cancer registries program

Over the past week, as cancer control experts scoured through a confidential budget document called the “passback” budget, they haven’t been able to find any trace of a relatively small but highly impactful program that funds state cancer registries.

April 25, 2025

By Paul Goldberg

Cancer Policy

HHS said it would terminate Women’s Health Initiative, then reconsidered

On April 21, Women’s Health Initiative investigators were informed that HHS would be terminating the WHI Regional Center contracts at the end of the current fiscal year.

April 25, 2025

By Jacquelyn Cobb and Claire Marie Porter

Cancer Policy

DOJ letters to peer-reviewed journals allege partisan bias in medical literature

At least two medical journals have received letters from the Trump administration accusing them of political bias.

April 25, 2025

By Claire Marie Porter

Tobacco Interests Contribute a Portion Of the $109 Million Raised by SU2C

YOU MAY BE INTERESTED IN

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

In her own words: Rathmell reflects on her priorities and values—and encourages everyone to do the same

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas

White House preliminary budget document provides no funds for highly impactful CDC cancer registries program

HHS said it would terminate Women’s Health Initiative, then reconsidered

DOJ letters to peer-reviewed journals allege partisan bias in medical literature

Renew today!

Subscriber content

Never miss an issue!

Login

Tobacco Interests Contribute a Portion Of the $109 Million Raised by SU2C

YOU MAY BE INTERESTED IN

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

In her own words: Rathmell reflects on her priorities and values—and encourages everyone to do the same

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industryCommissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas

White House preliminary budget document provides no funds for highly impactful CDC cancer registries program

HHS said it would terminate Women’s Health Initiative, then reconsidered

DOJ letters to peer-reviewed journals allege partisan bias in medical literature

Never miss an issue!

Login

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas